Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 834805, 10 pages
http://dx.doi.org/10.1155/2015/834805
Research Article

Gene Expression-Genotype Analysis Implicates GSDMA, GSDMB, and LRRC3C as Contributors to Inflammatory Bowel Disease Susceptibility

1Division of Medical Diagnostics, Ryhov County Hospital, 55185 Jönköping, Sweden
2Department of Medicine, Solna, Karolinska Institutet, 17176 Stockholm, Sweden
3Centre for Digestive Diseases, Karolinska University Hospital, 17176 Stockholm, Sweden

Received 28 June 2015; Accepted 6 September 2015

Academic Editor: Dimitrios P. Bogdanos

Copyright © 2015 Jan Söderman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Geboes and P. Van Eyken, “Inflammatory bowel disease unclassified and indeterminate colitis: the role of the pathologist,” Journal of Clinical Pathology, vol. 62, no. 3, pp. 201–205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. W. J. Tremaine, “Is indeterminate colitis determinable?” Current Gastroenterology Reports, vol. 14, no. 2, pp. 162–165, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. R. K. Russell and J. Satsangi, “IBD: a family affair,” Best Practice & Research: Clinical Gastroenterology, vol. 18, no. 3, pp. 525–539, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Jostins, S. Ripke, R. K. Weersma et al., “Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease,” Nature, vol. 491, no. 7422, pp. 119–124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. C. A. Anderson, G. Boucher, C. W. Lees et al., “Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47,” Nature Genetics, vol. 43, no. 3, pp. 246–252, 2011. View at Publisher · View at Google Scholar
  6. J. C. Barrett, S. Hansoul, D. L. Nicolae et al., “Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease,” Nature Genetics, vol. 40, no. 8, pp. 955–962, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. F. Moffatt, M. Kabesch, L. Liang et al., “Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma,” Nature, vol. 448, no. 7152, pp. 470–473, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. P. B. McGovern, A. Gardet, L. Törkvist et al., “Genome-wide association identifies multiple ulcerative colitis susceptibility loci,” Nature Genetics, vol. 42, no. 4, pp. 332–337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Franke, D. P. McGovern, J. C. Barrett et al., “Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci,” Nature Genetics, vol. 42, no. 12, pp. 1118–1125, 2010. View at Google Scholar
  10. J. Vandesompele, K. De Preter, F. Pattyn et al., “Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes,” Genome Biology, vol. 3, no. 7, Article ID RESEARCH0034, 2002. View at Google Scholar · View at Scopus
  11. C. L. Andersen, J. L. Jensen, and T. F. Ørntoft, “Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets,” Cancer Research, vol. 64, no. 15, pp. 5245–5250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. J. C. Barrett, D. G. Clayton, P. Concannon et al., “Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes,” Nature Genetics, vol. 41, no. 6, pp. 703–707, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. F. A. S. Kurreeman, E. A. Stahl, Y. Okada et al., “Use of a multiethnic approach to identify rheumatoid- arthritis-susceptibility loci, 1p36 and 17q12,” The American Journal of Human Genetics, vol. 90, no. 3, pp. 524–532, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. G. M. Hirschfield, X. Liu, Y. Han et al., “Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis,” Nature Genetics, vol. 42, no. 8, pp. 655–657, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Hao, Y. Bossé, D. C. Nickle et al., “Lung eQTLs to help reveal the molecular underpinnings of asthma,” PLoS Genetics, vol. 8, no. 11, Article ID e1003029, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. D. R. Crosslin, A. McDavid, N. Weston et al., “Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network,” Human Genetics, vol. 131, no. 4, pp. 639–652, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Soranzo, T. D. Spector, M. Mangino et al., “A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium,” Nature Genetics, vol. 41, no. 11, pp. 1182–1190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. D. J. Verlaan, S. Berlivet, G. M. Hunninghake et al., “Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease,” The American Journal of Human Genetics, vol. 85, no. 3, pp. 377–393, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C.-T. Ong and V. G. Corces, “CTCF: an architectural protein bridging genome topology and function,” Nature Reviews Genetics, vol. 15, no. 4, pp. 234–246, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Grundberg, K. S. Small, Å. K. Hedman et al., “Mapping cis- and trans-regulatory effects across multiple tissues in twins,” Nature Genetics, vol. 44, no. 10, pp. 1084–1089, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Kabakchiev and M. S. Silverberg, “Expression quantitative trait loci analysis identifies associations between genotype and gene expression in human intestine,” Gastroenterology, vol. 144, no. 7, pp. 1488.e3–1496.e3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Haglund, S. Almer, C. Peterson, and J. Söderman, “Gene expression and thiopurine metabolite profiling in inflammatory bowel disease—novel clues to drug targets and disease mechanisms?” PLoS ONE, vol. 8, no. 2, Article ID e56989, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Saeki, D. H. Kim, T. Usui et al., “GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling,” Oncogene, vol. 26, no. 45, pp. 6488–6498, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Saeki, T. Usui, K. Aoyagi et al., “Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium,” Genes Chromosomes & Cancer, vol. 48, no. 3, pp. 261–271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Haraldson, V. I. Kashuba, A. A. Dmitriev et al., “LRRC3B gene is frequently epigenetically inactivated in several epithelial malignancies and inhibits cell growth and replication,” Biochimie, vol. 94, no. 5, pp. 1151–1157, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Kim, J.-H. Kim, H.-R. Jang et al., “LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer,” Cancer Research, vol. 68, no. 17, pp. 7147–7155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. Y.-N. Lin, A. Roy, W. Yan, K. H. Burns, and M. M. Matzuk, “Loss of zona pellucida binding proteins in the acrosomal matrix disrupts acrosome biogenesis and sperm morphogenesis,” Molecular and Cellular Biology, vol. 27, no. 19, pp. 6794–6805, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J. L. Eyles, A. W. Roberts, D. Metcalf, and I. P. Wicks, “Granulocyte colony-stimulating factor and neutrophils—forgotten mediators of inflammatory disease,” Nature Clinical Practice Rheumatology, vol. 2, no. 9, pp. 500–510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. L. Eyles, M. J. Hickey, M. U. Norman et al., “A key role for G-CSF induced neutrophil production and trafficking during inflammatory arthritis,” Blood, vol. 112, no. 13, pp. 5193–5201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. B. M. Fournier and C. A. Parkos, “The role of neutrophils during intestinal inflammation,” Mucosal Immunology, vol. 5, no. 4, pp. 354–366, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Billot, C. Parizot, I. Arrouss et al., “Differential aiolos expression in human hematopoietic subpopulations,” Leukemia Research, vol. 34, no. 3, pp. 289–293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Zhuang, D. Li, J. Fu, Q. Shi, Y. Lu, and X. Ju, “Overexpression of AIOLOS inhibits cell proliferation and suppresses apoptosis in Nalm-6 cells,” Oncology Reports, vol. 31, no. 3, pp. 1183–1190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Sun, G. Matthias, M. J. Mihatsch, K. Georgopoulos, and P. Matthias, “Lack of the transcriptional coactivator OBF-1 prevents the development of systemic lupus erythematosus-like phenotypes in Aiolos mutant mice,” Journal of Immunology, vol. 170, no. 4, pp. 1699–1706, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Wang, Y. Murakami, T. Yasui et al., “Significance of glycosylphosphatidylinositol-anchored protein enrichment in lipid rafts for the control of autoimmunity,” The Journal of Biological Chemistry, vol. 288, no. 35, pp. 25490–25499, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. Q. Li, D. Wang, J. Li, and P. Chen, “Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas,” BMC Cancer, vol. 11, article 277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. S. E. Wang, “The functional crosstalk between HER2 tyrosine kinase and TGF-β signaling in breast cancer malignancy,” Journal of Signal Transduction, vol. 2011, Article ID 804236, 8 pages, 2011. View at Publisher · View at Google Scholar
  37. P.-Y. Chu, L.-Y. Huang, C.-H. Hsu et al., “Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesis,” The Journal of Biological Chemistry, vol. 284, no. 30, pp. 20215–20226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Ramsey, T. Bai, A. Hanlon Newell et al., “GRB7 protein over-expression and clinical outcome in breast cancer,” Breast Cancer Research and Treatment, vol. 127, no. 3, pp. 659–669, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Dasgupta, L. M. Wasson, N. Rauniyar, L. Prokai, J. Borejdo, and J. K. Vishwanatha, “Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells,” Oncogene, vol. 28, no. 32, pp. 2860–2872, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. E. E. Evans, A. D. Henn, A. Jonason et al., “C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer,” Molecular Cancer Therapeutics, vol. 5, no. 11, pp. 2919–2930, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Goto and H. Kiyono, “Epithelial barrier: an interface for the cross-communication between gut flora and immune system,” Immunological Reviews, vol. 245, no. 1, pp. 147–163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. H. H. Uhlig, “Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease,” Gut, vol. 62, no. 12, pp. 1795–1805, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Vereecke, R. Beyaert, and G. van Loo, “Enterocyte death and intestinal barrier maintenance in homeostasis and disease,” Trends in Molecular Medicine, vol. 17, no. 10, pp. 584–593, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Sturm, H. S. P. de Souza, and C. Fiocchi, “Mucosal T cell proliferation and apoptosis in inflammatory bowel disease,” Current Drug Targets, vol. 9, no. 5, pp. 381–387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Knights, K. G. Lassen, and R. J. Xavier, “Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome,” Gut, vol. 62, no. 10, pp. 1505–1510, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Wlodarska, A. Kostic, and R. Xavier, “An integrative view of microbiome-host interactions in inflammatory bowel diseases,” Cell Host & Microbe, vol. 17, no. 5, pp. 577–591, 2015. View at Publisher · View at Google Scholar
  47. M. Caliskan, Y. A. Bochkov, E. Kreiner-Moller et al., “Rhinovirus wheezing illness and genetic risk of childhood-onset asthma,” The New England Journal of Medicine, vol. 368, no. 15, pp. 1398–1407, 2013. View at Google Scholar
  48. L. A. M. Smit, E. Bouzigon, I. Pin et al., “17q21 Variants modify the association between early respiratory infections and asthma,” The European Respiratory Journal, vol. 36, no. 1, pp. 57–64, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. J. M. Norman, S. A. Handley, M. T. Baldridge et al., “Disease-specific alterations in the enteric virome in inflammatory bowel disease,” Cell, vol. 160, no. 3, pp. 447–460, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. W. Wang, J. Jovel, B. Halloran et al., “Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria,” Inflammatory Bowel Diseases, vol. 21, no. 6, pp. 1419–1427, 2015. View at Publisher · View at Google Scholar